by John Conrad | Jul 17, 2024 | NewsBrief
A groundbreaking medical device designed to improve breast cancer treatment has successfully completed its first human trial. Innoblative Designs, Inc., a Chicago-based medical device company, announced on July 16, 2024, that its SIRA® RFA Electrosurgical Device was...
by John Conrad | Jul 11, 2024 | NewsBrief
Chicago-based ImmersiveTouch Inc. has announced a major breakthrough in medical technology with FDA 510(k) clearance for its augmented reality (AR) surgical platform, ImmersiveAR™. This innovative system is set to transform operating room procedures by bringing...
by John Conrad | Jul 10, 2024 | NewsBrief
Exciting news has emerged from the field of genetic medicine, as Jaguar Gene Therapy announces plans to initiate its first pediatric clinical trial for a novel gene therapy targeting a specific genetic form of autism spectrum disorder (ASD) and Phelan-McDermid...
by John Conrad | Jul 10, 2024 | NewsBrief
In a significant move that’s making waves across the pharmaceutical industry, AbbVie (NYSE:ABBV) has just announced a major change in its leadership team. Dr. Roopal Thakkar, a veteran of the company with over two decades of experience, has been appointed as the...
by John Conrad | Jul 10, 2024 | NewsBrief
University of Chicago researchers have made a groundbreaking discovery in the field of immunology, potentially opening up new avenues for fighting disease. In a recent study, the team identified several small molecule compounds capable of inducing “trained...
by John Conrad | Jul 8, 2024 | NewsBrief
The heart of Illinois is set to become a global leader in biomanufacturing, thanks to a significant $51 million federal grant awarded to the Illinois Fermentation and Agriculture Biomanufacturing (iFAB) Tech Hub. This exciting development promises to transform the...
